chrisvoncsefalvay/vaers-outcomes huggingface dataset:
bruise in the left hand over their ring finger knuckle and the middle ginger knuckle; very tender to the touch; a little swollen; a little body aches; chills; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (bruise in the left hand over their ring finger knuckle and the middle ginger knuckle), TENDERNESS (very tender to the touch), SWELLING (a little swollen), MYALGIA (a little body aches) and CHILLS (chills) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Dec-2021, the patient experienced MYALGIA (a little body aches) and CHILLS (chills). On 15-Dec-2021, the patient experienced CONTUSION (bruise in the left hand over their ring finger knuckle and the middle ginger knuckle), TENDERNESS (very tender to the touch) and SWELLING (a little swollen). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. On 14-Dec-2021, MYALGIA (a little body aches) and CHILLS (chills) had resolved. At the time of the report, CONTUSION (bruise in the left hand over their ring finger knuckle and the middle ginger knuckle), TENDERNESS (very tender to the touch) and SWELLING (a little swollen) outcome was unknown.      Concomitant included medications for birth control.
This spontaneous report was received from a nurse referring to unspecified number of patients of unknown age. On an unknown date unspecified number of the patients were vaccinated with improperly stored VARIVAX, subcutaneous (dose not reported). VARIVAX and PROQUAD, have been exposed to -14 degree Centigrade for 60 hours. No adverse effects reported. The outcome of the events was unknown. The causality of the events was unspecified. There was no PQC reported. The case has been linked with the case 1406USA006872 (same patient link). Additional information has been requested.
Pt recvd 2nd dose of vax in 1989 & following vax had general feeling of weakness & muscle aches; pt felt as if was coming down w/something;
3 Hours after Vaccine Pain in Arm & fever. Nausea, Chills, fatigue, light Headed - Pain in Right Arm Ice, Ibuprofen, return if fever continues or worsening
my husband got the flu everytime he got the shot; Initial information regarding this unsolicited valid non-serious social media case received from a non-healthcare professional (patient`s wife) on 12-Nov-2020.  This case involves a male patient with unknown age for whom it was reported that my husband got the flu every time he got the shot (Influenza), when received vaccine influenza vaccine (Flu shot).  Relevant medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, (latency unknown) after administration of influenza vaccine, the reporter reported that my husband got the flu every time he got the shot (Influenza).  Relevant laboratory test was not reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome was unknown for the reported event.  There will be no information available on batch number for this case.
Pt presented to the vaccination site on 02/02/2022. The client reported that he received a 2nd dose of Moderna COVID vaccine on 02/07/2021 (Client reported no reaction to his 1st dose of Moderna COVID vaccine received on 01/13/2021). Vaccinator  elevated situation to Lead RN. Client reported tinnitus, nausea, vomiting, vertigo and hearing loss starting in September 2021. Patient saw ENT doctor in October 2021 and was diagnosed with Meniere's disease. Patient reported his ENT doctor didn't think Meniere's disease is related to the Moderna COVID vaccine. Patient did not follow up with ENT or PCP for booster approval. Patient reported history of hypertension and takes hydrochlorothiazide. Patient denied allergic reaction with his 1st and 2nd doses of the Moderna COVID vaccine. Lead Nurse elevated to Clinical Project Coordinators requesting to proceed with the booster dose of Pfizer COVID vaccine.  Per medical consult team, approval to proceed with the booster dose of the Pfizer COVID vaccine was obtained. Client received a booster dose of Pfizer COVID vaccine (LOT# FK9896) on 02/02/2022. The client did not report any symptoms during the 30-minute observation period. Lead RN educated client on possible adverse reactions, when to seek medical care and to register with V-Safe. The client left the vaccination site at approximately 1400 with unlabored respirations and steady gait.
colitis difficile (c-diff); This spontaneous case was reported by a consumer and describes the occurrence of CLOSTRIDIUM DIFFICILE COLITIS (colitis difficile (c-diff)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CLOSTRIDIUM DIFFICILE COLITIS (colitis difficile (c-diff)) (seriousness criterion medically significant). At the time of the report, CLOSTRIDIUM DIFFICILE COLITIS (colitis difficile (c-diff)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication was not reported.  Treatment details not reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  Company Comment: This is a Spontaneous case reported by a consumer, concerning a female patient of unknown age, with no medical history reported, who experienced the unexpected and serious (due to medically significant) event of Clostridium difficile colitis, which occurred after an unspecified dose of mRNA-1273 vaccine. Since no vaccination dates were provided, temporal association and latency cannot be properly assessed. No information disclosed about diagnostic tests performed, clinical course or treatments received. The benefit-risk relationship of mRNA-1273 vaccine, is not affected by this report.; Sender's Comments: This is a Spontaneous case reported by a consumer, concerning a female patient of unknown age, with no medical history reported, who experienced the unexpected and serious (due to medically significant) event of Clostridium difficile colitis, which occurred after an unspecified dose of mRNA-1273 vaccine. Since no vaccination dates were provided, temporal association and latency cannot be properly assessed. No information disclosed about diagnostic tests performed, clinical course or treatments received. The benefit-risk relationship of mRNA-1273 vaccine, is not affected by this report.
cellulitis of lt arm, approx 5cm x 15cm, around inj site;heat from erythematous area;+ fever;+ malaise;pt felt tired x 2hr p/vax;rash noticeable about 8hr p/inj;allerg rxn;
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 31-MAR-2017, the patient was vaccinated with improprerly stored dose of M-M-R II lot # M002418 with an expiration date 12-JAN-2018 for prophylaxis (dose, route of administration and anatomical location were not reported). There was no adverse effect reported. Administered dose of M-M-R II experienced the temperature excursion of -14.4 degrees Celsius for 54 minutes. There was no previous temperature excursion reported. A digital data logger was involved. This is one of several reports received from the same reporter. Additional information is not expected, all information has already been obtained.; Sender's Comments: US-009507513-1611USA011831: US-009507513-1611USA004113: US-009507513-1705USA009742:Original Case : 1705USA009742.
I started feeling bad on April 14th. After 5 or 6 days, I called my doctor and went to the HCF center to have a COVID test done. I was notified that it was positive. I called the doctor back and advised it was positive. He prescribed azithromycin tablets. I am feeling better but still a bit tired with sore throat. I took Claritin and gargled with salt water for my throat, I continued to not feel so I retested on April 27, and still came up positive. I tested again 3 days later and still came up as positive. I tested positive again May 30 after isolating for 20 days. I called the nurse practitioner who ordered another test. I have not received the results yet. I was told that you could get positive readings for up to 3 months. I was advised that I was no longer contagious. I never had fever but I did lose my sense of taste. I am still tired a lot and experiencing weakness. I have issues with my sinuses but I am no longer coughing.
Patient was asked prior to administration of mRNA Pfizer Covid vaccine if this was her first dose of the covid vaccine t which she replied "yes". The consent form also noted that this was her first dose based on question asked. After dose was administered and further inquiry the patient stated that she had received the Moderna covid mRNA  vaccine about 4 months ago through her previous job. Later we verified that it was given on 12/30/2020. We informed her that it is recommended that the 2nd dose be the same product rather than mixing product due to lack of studies. We informed her that he 2nd appt for Pizer vaccine would be cancelled since no additional doses of either product are recommended at this time, according to CDC .
Pain to (R) arm et decreased ROM 1 day after Tdap. Pain worse with movement. Nausea 2 days after administration. Tx: Ice/heat/ibuprofen/TYLENOL F/U PRN. No associated redness, swelling, warmth, numbness or tingling.
slight elevated heart rate; was white as a ghost; itching; face also swelled; This is a spontaneous report from a contactable consumer (patient's mother).  A female patient of an unspecified age received the first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number and Expiration Date: Not Provided), via an unspecified route of administration in Dec2020 at a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported. On an unspecified date in Dec2020, the patient experienced: slight elevated heart rate, was white as a ghost, itching, face also swelled; which were all assessed as non-serious. The clinical course was reported as follows:  The patient's mother stated that her daughter was a grown woman and did not know that the she was calling Pfizer. The patient's mother stated that her daughter had the COVID vaccine on a Wednesday (as reported), and the patient was kept for 15 minutes after the administration. The patient's mother stated that her daughter had a slightly elevated heart rate, and her daughter's husband said that she was white as a ghost. The patient's mother stated that her daughter also experienced itching, that did require antihistamines. The patient's mother stated that her daughter called the hospital, and they just said that they will make a note of it. The patient's mother stated that as a parent, she was slightly worried about her daughter getting the second dose; however, she was more concerned about her daughter getting COVID.  The patient's mother also stated that her daughter's face also swelled after getting the vaccine, but that her daughter did not have any closing of the throat. The patient did have to go to get antihistamines. The patient's doctors did not tell the patient that she needed to pre-medicate with antihistamines next time. The patient underwent lab tests and procedures which included heart rate: slightly elevated in Dec2020.  Therapeutic measures were taken as a result of itching. The clinical outcome of the events was unknown.  The batch/lot numbers for the vaccine, PFIZER-BIONTECH COVID-19 MRNA VACCINE, were not provided and will be requested during follow up.
Temp to 106 av on 16MAY91 intermittently thru 19MAY91, hacking cough 16MAY91 thru 20MAY91;
On day of vaccine developed headache and felt warm. The next morning felt dizzy, nausea, vomited twice and had pain in mid epigastric region and lower anterior ribs.
hurted so bad, almost in "tears"; This case was reported by a consumer via  interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was recovered/resolved.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.  Additional details provided were as follows: The case was reported by patient for himself/herself. The age at vaccination was not reported. The patient received a shot of Shingles vaccine and first it hurted so bad was almost in tears. Follow-up would not be possible as no contact details available. For tolerance of 2nd shot, refer case US2021AMR241128, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR241128:same reporter - 2nd dose
This spontaneous report was received from a 60 year old female patient regarding herself. The concurrent condition and medical history was not reported. The patient was allergic to codeine, sulfa drugs and VIOXX. She had no other pertinent medical histories. On 21-APR-2016, the patient was vaccinated with 1 dose of ZOSTAVAX on the back of her left arm in her tricep (incorrect route of drug administration) (dose and lot details unavailable). The concomitant medication was not reported. On the same day evening she developed itching, burning and redness around the injection site. Patient stated the area around the injection site felt "feverish" and looked very red and was hard to the touch and the reaction was approximately "the size of a golf ball". Patient also mentioned that the shot was "very painful". She also developed a "discolored location" on her arm around the injection site which still has persisted to the date of report. She applied BENADRYL cream a couple of times on her arm to try to relieve the itching she was experiencing. No lab testes were done. She saw her pharmacist on 03-MAY-2015 (about 30 minutes ago on the day of reporting) to let them know about her adverse reaction to the vaccine. The outcome of injection site discolouration was reported as not recovered. The outcome of all other events were resolving. The causality was not specified. Additional information has been requested.
Narrative: COVID infection after completion of COVID vaccine series: 06/25/2021 COVID vaccine dose (J&J) 06/30/2021 Pt reported onset of chills, diarrhea, sore throat, cough, loss of appetite and associated weight loss 07/12/2021 Pt presented to ED c/o continued symptoms 07/12/2021 COVID positive per nasopharyngeal swab 07/21/2021 Clinical resolutions of COVID infection
Event occurred after 2nd dose. Patient was diagnosed with Covid Aspirin, Remdesivir In-patient
Fever, chills,stiffness, nausea, diarrhea, headache
Information has been received regarding a case in litigation concerning male child who, for the first two years of his life, was vaccinated with injections containing the dangerous and highly toxic mercury based preservative thimerosal. The alleged result of these vaccinations is that the patient now suffers from, and in the future will continue to suffer from, the toxic neurological effects of mercury poisoning. Immunization records have been received as follow up. It was reported that the patient was vaccinated with a first dose of hepatitis B vaccine recombinant (yeast) (lot #616324/0409D given in the rigth thigh on 8/30/96; dose two through four were given on 5/30/97 (lot # not reported), 9/12/97 (lot# 622792/0312E), and 12/29/97 (lot #624329/1225E) and a fifth dose of hepatitis B vaccine, recomb (ENGERIX-B)(lot#ENG2145A was given in the right thigh on 2/3/97). Concomitant vaccines included MMR (lot#619384/0104E given in the left thigh on 7/31/97); lot #624725/1305E given 4/20/98), varicella virus vaccine live (lot#624645/1330E given on 4/20/98), diphtheria toxoid (-) Haemophilus B conjugate vaccine (+) pertussis vaccine (+) tetanus toxoid (ACTHIB/DTP)(lot #6411095 given IM in the left thigh on 10/8/96; lot# 6L71162 given IM in the left thigh on 12/9/96; lot # 6L71162 given IM in the left thigh on 2/3/97), diphtheria toxoid (+) Haemophilus B conjugate vaccine (+) pertussis vaccine (+) tetanus toxoid (TRIHIBIT) lot #7B01925 given in the left thigh on 1/29/98), oral poliovirus vaccine (ORIMUNE)(lot #0749L given 10/8/96; lot #0750A given 12/9/96 and 2/3/97; lot # 0722H given 1/29/98) oral poliovirus vaccine, manufacturer not reported, (lot # not provided for dose given on 5/30/97; lot #0770E given 9/12/97; lot #0793C given 10/21/98), diphtheria toxoid/pertussis vaccine/teta, manufacturer not reported, (lot# not reported for dose given 5/30/97; lot #7B81602 given 8/6/97; lot # 7B91821 given 10/14/97; lot # 0930790 given 10/21/98), HIB conjugate vaccine, manufacturer not reported (lot # not provided for dose given on 5/30/97; lot #7B91619 given 8/6/97; lot #7091845 given 10/14/97; lot # 0947790 given 7/16/98, and tuberculin purified protein derivative (lot # not provided, skin tests started on 4/20/97 and 6/29/99; results were not provided). Upon internal review, toxic neurological effect and mercury poisoning were determined to be other important medical events. No further information is available. A 15-day follow up report received 05/20/2003 adds: Follow up info received on 05/01/2003 reported that the dates of injection of vaccines that have been alleged as containing thimerosal include: 08/30/1996, 10/08/1996, 12/09/1996, 02/03/1997, 07/31/1997 and 01/29/1998. Upon internal review, toxic neurologic effects and mercury poisoning were considered other important medical events. No further info is available.
Rash on his stomach and it has red bumps; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH ERYTHEMATOUS (Rash on his stomach and it has red bumps) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced RASH ERYTHEMATOUS (Rash on his stomach and it has red bumps). The patient was treated with TRIAMCINOLONE (topical) for Rash, at a dose of 1 %. At the time of the report, RASH ERYTHEMATOUS (Rash on his stomach and it has red bumps) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.    Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Significant Follow-up received on 26-May-2021.Updated outcome for the rash to not resolved
Chills, fever of 103.0, weak, dizzy, headache, raised up painful welt at injection site - did not get that last time.  sweating, naseau,  I feel miserable
PATIENT RECEIVED THE FIRST DOSE OF MODERNA VACCINE WITHIN FIVE MINUTES PATIENT WAS DIAPHORETIC, LIGHTHEADED , AND HAD COMPLAINTS OF SHORTNESS OF BREATH.  PATIENT WAS TRANSPORTED TO ER PER WHEELCHAIR PATIENT REQUIRE BENADRYL, IV FLUIDS, AND SOLUMEDROL. PATIENT REPORTED SYMPTOMS RESOLVED AND  PATIENT WAS DISCHARGED FROM ER AND INSTRUCTED TO FOLLOW UP WITH PRIMARY CARE PHYSICIAN IF NEEDED.
I received the vaccination at 0844 on Jan 4, by 1400 my arm was incredibly sore but I experienced no other symptoms until about 1600 when I began to feel a chill. By that time my arm hurt so bad I did not want to move it. When I woke up for work on Jan 5 I was exhausted and feverish. I took my temperature about 0600 and it was 101, by 0900 my temp had spiked to 103.8. Using fever reducers I was able to bring my temperature down later in the afternoon on Jan 5. By the time I woke up on Jan 6 I felt completely fine.
I NOW HAVE  GRAVES DISEASE - DUE TO THIS VACCINE!! I WILL NOW BE ON MEDICATION FOR NO LESS THAN ONE YEAR - OR FOR THE REST OF MY LIFE! THIS IS UNACCEPTABLE. THE PUBLIC HAS THE RIGHT TO KNOW!
6/27 fevers, chills aches 6/28 injection site redness, hard, and painful
Friday morning1/8/21 at 0645 when awaking it felt like my right nostril was congested and it was hard to breath, also the tip of my nose was bright red, swollen and tender to touch. throughout the day the swelling, redness and pain increased with the right side of my nose. breathing did get easier.  Saturday 1/9/21 the right side of my nose was still presenting with symptoms listed above and continued to grow toward my right eye. Sunday 1/10/21 the swelling increased but redness and pain stayed the same as the previous day.  Ice was applied with mild improvement. No medication was taken. Monday 1/11/21 swelling on the right side of the nose has slightly gone down, minimal swelling (puffiness) under the right eye had started.
generalize papular rash; very itchy, 4 days post vaccine, lasted 48hrs; treated with Benadryl
She began having seizures after she woke up from the vaccine. She was shaking with her eyes rolled back. This lasted for several months to a year. They would last about 30 seconds to a minute each time.  After a long time she now will just stare into space at times.
Started with nausea then GI bleed then severe nausea (lost 8 lbs), severe dizziness and headache accompanied by numbness of left plantar foot. Sxs prompted visits to ER, MDs x2. Debilitating results of dizziness and numbness prevented her from ambulating straight and missing school. Sxs still exist up to this time 1/15.
Chills, lethargic 10 minutes after the infection chills immediately after injection.